Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity

Table 2

Late effects in normal tissues subjective, objective, management and analytic scales (LENT/SOMA) data: number of patients with maximum scores per symptom area (percentage of patients in parentheses).

	Bowel function			Bladder function			Sexual function
Grade	Baseline	2 years	7 years	Baseline	2 years	7 years	Baseline	2 years	7 years
0	15 (56)	10 (48)	8 (29)	2 (7)	1 (5)	2 (7)	0 (0)	0 (0)	0 (0)
1	4 (15)	1 (5)	3 (11)	6 (22)	6 (29)	5 (19)	0 (0)	0 (0)	0 (0)
2	4 (15)	2 (10)	7 (25)	9 (33)	12 (57)	5 (19)	1 (4)	2 (11)	5 (21)
3	4 (15)	5 (24)	8 (29)	10 (37)	2 (10)	14 (52)	1 (4)	2 (11)	2 (8)
4	0 (0)	3 (14)	2 (7)	0 (0)	0 (0)	1 (4)	22 (92)	14 (78)	17 (71)